Sichuan Nangle Biotechnology Co., Ltd. was established on 20 13-06-08, and its business scope includes research, development and production: Class III 6866 medical polymer materials and products, large-capacity injections (including blood preservation solution) and small-capacity injections; Research, development and production: Class III 6845 extracorporeal circulation and blood treatment equipment; Engaged in the export business of self-produced products and technologies of enterprises (the production and sales of medical devices and drugs in all the above projects shall be operated according to the scope, address and validity period approved by the pharmaceutical supervisory and administrative department); Engaged in the import and export business of raw and auxiliary materials, instruments and meters, mechanical equipment, spare parts and technologies needed for the production of this enterprise and its member enterprises (except for commodities and technologies restricted and prohibited by the state); Enterprise marketing planning; Marketing planning; Market information consultation and investigation; Corporate image planning; Conference services; Exhibition service; Exhibition service; Engaged in technical development, technical consultation and technical services in the fields of medicine and medical science and technology; Technological development in the field of biotechnology; Research, development, design and sales of computer software and hardware, system integration and application software; Computer network engineering, information system integration, information technology consulting services. (Projects subject to approval according to law can only be operated after approval by relevant departments).
More peer analysis, the company knows and understands.